Findings

What do systematic reviews say?

6 questions · 6 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 4 · 66.7%Very low 0 · 0%Low 2 · 33.3%Moderate 0 · 0%High 0 · 0%

Symptomatic DVT · participants at risk of venous thromboembolism

1 finding from 1 review

Neuromuscular electrical stimulation for the prevention of venous thromboembolism 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 31 participants
GRADE not reported

Asymptomatic DVT · participants at risk of venous thromboembolism

1 finding from 1 review

Neuromuscular electrical stimulation for the prevention of venous thromboembolism 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 31 participants
GRADE not reported

Symptomatic DVT · participants at risk of venous thromboembolism

1 finding from 1 review

Neuromuscular electrical stimulation for the prevention of venous thromboembolism 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 32 participants
GRADE not reported

Asymptomatic DVT · participants at risk of venous thromboembolism

1 finding from 1 review

Neuromuscular electrical stimulation for the prevention of venous thromboembolism 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 32 participants
GRADE not reported

Symptomatic DVT · participants at risk of venous thromboembolism

NMES showed no clear difference in symptomatic DVT compared with low‐dose heparin (low certainty).

1 finding from 1 review

Neuromuscular electrical stimulation for the prevention of venous thromboembolism 2017 · Cochrane Headline outcomes only
OR 0.4 [0.02, 10.07]
1 study · 89 participants
Low

Asymptomatic DVT · participants at risk of venous thromboembolism

NMES showed no clear difference in asymptomatic DVT compared with low‐dose heparin (low certainty).

1 finding from 1 review

Neuromuscular electrical stimulation for the prevention of venous thromboembolism 2017 · Cochrane Headline outcomes only
OR 1.61 [0.4, 6.43]
1 study · 89 participants
Low